Analyst Valuation and EPS Growth FSD Pharma (NYSE:HUGE)

Earnings results for FSD Pharma (NYSE:HUGE)

FSD Pharma Inc. is estimated to report earnings on 08/13/2021. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.51.

FSD Pharma last issued its earnings data on May 7th, 2021. The reported ($0.35) earnings per share for the quarter. FSD Pharma has generated $0.00 earnings per share over the last year. FSD Pharma has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Friday, August 13th, 2021 based off prior year’s report dates.

Analyst Opinion on FSD Pharma (NYSE:HUGE)

1 Wall Street analysts have issued ratings and price targets for FSD Pharma in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of “Buy.”

Dividend Strength: FSD Pharma (NYSE:HUGE)

FSD Pharma does not currently pay a dividend. FSD Pharma does not have a long track record of dividend growth.

Insiders buying/selling: FSD Pharma (NYSE:HUGE)

In the past three months, FSD Pharma insiders have not sold or bought any company stock.

Earnings and Valuation of FSD Pharma (NYSE:HUGE

More latest stories: here